Understanding Ehlers-Danlos Syndrome Type VIA
Author Information
Author(s): Marianne Rohrbach, Anthony Vandersteen, Uluç Yiş, Gul Serdaroglu, Esra Ataman, Maya Chopra, Sixto Garcia, Kristi Jones, Ariana Kariminejad, Marius Kraenzlin, Carlo Marcelis, Matthias Baumgartner, Cecilia Giunta
Primary Institution: University Children's Hospital and Children's Research Centre, Zurich, Switzerland
Hypothesis
The study aims to characterize the clinical, molecular, and biochemical features of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA).
Conclusion
EDS VIA is a highly variable condition that can present with a wide range of symptoms, including cognitive delays and increased risk of vascular events.
Supporting Evidence
- The study identified a broad spectrum of clinical features in patients with EDS VIA.
- Significant variability in the age of diagnosis and severity of symptoms was observed.
- Urinary pyridinoline cross-links were found to be a reliable diagnostic test for EDS VIA.
- Five patients exhibited developmental delays, which is not typically associated with EDS VIA.
Takeaway
EDS VIA is a rare disease that affects how the body makes collagen, leading to problems like weak muscles and flexible joints. Some kids with this condition might also have trouble learning.
Methodology
The study involved clinical, biochemical, and molecular characterization of 15 newly diagnosed patients with EDS VIA.
Potential Biases
Potential bias may arise from the reliance on clinical diagnosis and the variability in patient reporting.
Limitations
The study is limited by the small sample size and the variability in clinical presentation among patients.
Participant Demographics
Participants included 53% males and 47% females, with a majority from Turkey, former Yugoslavia, and the Middle East.
Statistical Information
P-Value
0.02
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website